Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.

Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease. Clin Endocrinol (Oxf) (2004) 1.62

Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol (2008) 1.04

Quality of life in European patients with Addison's disease: validity of the disease-specific questionnaire AddiQoL. J Clin Endocrinol Metab (2011) 0.85

Identification of TPIT and other novel autoantigens in lymphocytic hypophysitis: immunoscreening of a pituitary cDNA library and development of immunoprecipitation assays. Eur J Endocrinol (2011) 0.85

Isolated secondary adrenal insufficiency--an underestimated consequence of asymptomatic autoimmune hypophysitis. Clin Endocrinol (Oxf) (2011) 0.81

Three-dimensional sonography in diagnosis of retroperitoneal hemorrhage from adrenocortical carcinoma. J Ultrasound Med (2004) 0.81

The role of combined low-dose dexamethasone suppression test and desmopressin stimulation test in the diagnosis of persistent Cushing's disease. Case report. Endokrynol Pol (2010) 0.80

Chromogranin A (CgA)--the influence of various factors in vivo and in vitro, and existing disorders on it's concentration in blood. Endokrynol Pol (2010) 0.78

The differences in chromogranin A (CgA) concentrations measured in serum and in plasma by IRMA and ELISA methods. Endokrynol Pol (2010) 0.77

Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS)--the effect of metformin treatment. Endokrynol Pol (2014) 0.77

[Chromogranin A (CgA) - the influence of various factors in vivo and in vitro, and existing disorders on it's concentration in blood]. Endokrynol Pol (2011) 0.76

Bilateral, incidentally found adrenal tumours - results of observation of 1790 patients registered at a single endocrinological centre. Endokrynol Pol (2010) 0.75

Commentary to "chromogranin a: biological function and clinical utility in neuroendocrine tumor disease". Ann Surg Oncol (2010) 0.75

Addison's Disease Revisited in Poland: Year 2008 versus Year 1990. Autoimmune Dis (2010) 0.75

Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays: the importance of protein matrix effects. Clin Endocrinol (Oxf) (2013) 0.75

Possible explanations for the results of CRASH. Lancet (2005) 0.75

A woman who gained weight and became schizophrenic. Lancet (2003) 0.75

Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab (2002) 0.75

Prognostic value of circulating chromogranin A levels in acute coronary syndrome. Eur Heart J (2009) 0.75

[Chromogranin A (CgA) - characteristic of the currently available laboratory methods and conditions which can influence the results]. Endokrynol Pol (2009) 0.75

ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome. Neuro Endocrinol Lett (2005) 0.75

Chromogranin A (CgA) in adrenal tumours. Endokrynol Pol (2013) 0.75

Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males. Endokrynol Pol (2015) 0.75

Fetuin-A levels in lean and obese women with polycystic ovary syndrome. Endokrynol Pol (2014) 0.75